Wendy E Rieder Insider Trading $SNTA MADRIGAL PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Wendy E Rieder.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Wendy E Rieder. Wendy E Rieder is Former SVP, Gen. Counsel in SYNTA PHARMACEUTICALS CORP ($SNTA) and SVP, Gen. Counsel in SYNTA PHARMACEUTICALS CORP ($SNTA) and VP, IP and Legal, Gen. Counsel in SYNTA PHARMACEUTICALS CORP ($SNTA).
Wendy E Rieder in MADRIGAL PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Wendy E Rieder: Former SVP, Gen. Counsel, SVP, Gen. Counsel, VP, IP and Legal, Gen. Counsel
Holdings: 26,280 shares
Latest Transaction: Jul 22 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Wendy E Rieder in MADRIGAL PHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 22 2016 | SNTA | SYNTA PHARMACEUTIC ... | Rieder Wendy E | Former SVP, Gen. Co ... | Payment of Exercise | F | 9.48 | 8,550 | 81,054 | 17,730 | 26.3 K to 17.7 K (-32.53 %) |
| Jul 22 2016 | SNTA | SYNTA PHARMACEUTIC ... | Rieder Wendy E | Former SVP, Gen. Co ... | Grant | A | 0.00 | 25,714 | 0 | 26,280 | 566 to 26.3 K (+4,543.11 %) |
| Oct 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | Rieder Wendy E | SVP, Gen. Counsel | Option Exercise | A | 1.76 | 250,000 | 440,000 | 250,000 | |
| Mar 04 2015 | SNTA | SYNTA PHARMACEUTIC ... | Rieder Wendy E | SVP, Gen. Counsel | Option Exercise | A | 2.38 | 100,000 | 238,000 | 100,000 | |
| Mar 05 2014 | SNTA | SYNTA PHARMACEUTIC ... | Rieder Wendy E | VP, IP and Legal, G ... | Option Exercise | A | 6.15 | 66,512 | 409,049 | 66,512 | |
| Mar 07 2013 | SNTA | SYNTA PHARMACEUTIC ... | Rieder Wendy E | VP, IP and Legal, G ... | Option Exercise | A | 9.65 | 52,143 | 503,180 | 52,143 | |
| Sep 17 2012 | SNTA | SYNTA PHARMACEUTIC ... | Rieder Wendy E | VP, IP and Legal, G ... | Option Exercise | A | 8.05 | 15,000 | 120,750 | 15,000 | |
| Jun 20 2012 | SNTA | SYNTA PHARMACEUTIC ... | Rieder Wendy E | VP, IP and Legal, G ... | Option Exercise | M | 2.49 | 7,170 | 17,853 | 16,530 | |
| Jun 20 2012 | SNTA | SYNTA PHARMACEUTIC ... | Rieder Wendy E | VP, IP and Legal, G ... | Sell | S | 6.00 | 7,170 | 43,020 | 19,823 | 27 K to 19.8 K (-26.56 %) |
| Jun 20 2012 | SNTA | SYNTA PHARMACEUTIC ... | Rieder Wendy E | VP, IP and Legal, G ... | Buy | M | 2.49 | 7,170 | 17,853 | 26,993 | 19.8 K to 27 K (+36.17 %) |
| Jun 06 2012 | SNTA | SYNTA PHARMACEUTIC ... | Rieder Wendy E | VP, IP and Legal, G ... | Option Exercise | M | 2.49 | 7,170 | 17,853 | 23,700 | |
| Jun 06 2012 | SNTA | SYNTA PHARMACEUTIC ... | Rieder Wendy E | VP, IP and Legal, G ... | Sell | S | 5.50 | 7,170 | 39,435 | 19,823 | 27 K to 19.8 K (-26.56 %) |
| Jun 06 2012 | SNTA | SYNTA PHARMACEUTIC ... | Rieder Wendy E | VP, IP and Legal, G ... | Buy | M | 2.49 | 7,170 | 17,853 | 26,993 | 19.8 K to 27 K (+36.17 %) |
| Mar 08 2012 | SNTA | SYNTA PHARMACEUTIC ... | Rieder Wendy E | VP, IP and Legal, G ... | Option Exercise | A | 4.22 | 48,760 | 205,767 | 48,760 | |
| Mar 03 2011 | SNTA | SYNTA PHARMACEUTIC ... | Rieder Wendy E | VP, IP and Legal, G ... | Option Exercise | A | 5.26 | 41,891 | 220,347 | 41,891 | |
| Mar 03 2011 | SNTA | SYNTA PHARMACEUTIC ... | Rieder Wendy E | VP, IP and Legal, G ... | Grant | A | 0.00 | 4,397 | 0 | 19,823 | 15.4 K to 19.8 K (+28.50 %) |
| Mar 03 2011 | SNTA | SYNTA PHARMACEUTIC ... | Rieder Wendy E | VP, IP and Legal, G ... | Sell | S | 5.25 | 5,284 | 27,762 | 15,426 | 20.7 K to 15.4 K (-25.51 %) |
| Mar 03 2010 | SNTA | SYNTA PHARMACEUTIC ... | Rieder Wendy E | VP, IP and Legal, G ... | Option Exercise | A | 4.02 | 38,220 | 153,644 | 38,220 | |
| Mar 03 2010 | SNTA | SYNTA PHARMACEUTIC ... | Rieder Wendy E | VP, IP and Legal, G ... | Grant | A | 0.00 | 5,284 | 0 | 20,710 | 15.4 K to 20.7 K (+34.25 %) |
| Apr 14 2009 | SNTA | SYNTA PHARMACEUTIC ... | Rieder Wendy E | VP, IP and Legal, G ... | Option Exercise | A | 2.49 | 30,870 | 76,866 | 30,870 | |
| Jan 06 2009 | SNTA | SYNTA PHARMACEUTIC ... | Rieder Wendy E | VP, IP and Legal, G ... | Sell | S | 6.18 | 5,000 | 30,888 | 15,426 | 20.4 K to 15.4 K (-24.48 %) |
| Feb 29 2008 | SNTA | SYNTA PHARMACEUTIC ... | Rieder Wendy E | VP, IP and Legal, G ... | Option Exercise | A | 8.82 | 28,980 | 255,604 | 28,980 | |
| Feb 28 2007 | SNTA | SYNTA PHARMACEUTIC ... | Rieder Wendy E | VP, IP and Legal, G ... | Option Exercise | A | 8.75 | 22,000 | 192,500 | 22,000 |
Page: 1